Patents by Inventor Vincent Manetta

Vincent Manetta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11033565
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: June 15, 2021
    Assignee: Galderma Holding SA
    Inventors: Vincent Manetta, Gary R. Watkins
  • Publication number: 20170281663
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 5, 2017
    Inventors: Vincent MANETTA, Gary R. WATKINS
  • Publication number: 20170281664
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 5, 2017
    Inventors: Vincent MANETTA, Gary R. WATKINS
  • Publication number: 20150306124
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: July 6, 2015
    Publication date: October 29, 2015
    Inventors: Vincent MANETTA, Gary R. WATKINS
  • Publication number: 20150306027
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: July 6, 2015
    Publication date: October 29, 2015
    Inventors: Vincent MANETTA, Gary R. WATKINS
  • Publication number: 20140336139
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: July 22, 2014
    Publication date: November 13, 2014
    Inventors: Vincent MANETTA, Gary R. WATKINS
  • Patent number: 8815816
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: August 26, 2014
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • Publication number: 20140051653
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Applicant: Galderma S.A.
    Inventors: Vincent MANETTA, Gary R. Watkins
  • Patent number: 8598129
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica milliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: December 3, 2013
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • Patent number: 8470788
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: June 25, 2013
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • Patent number: 8415311
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: April 9, 2013
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • Publication number: 20120258062
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: June 21, 2012
    Publication date: October 11, 2012
    Applicant: Galderma S.A.
    Inventors: Vincent MANETTA, Gary R. Watkins
  • Publication number: 20120077766
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: December 2, 2011
    Publication date: March 29, 2012
    Applicant: Galderma S.A.
    Inventors: Vincent MANETTA, Gary R. WATKINS
  • Patent number: 8093219
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: January 10, 2012
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • Patent number: 8080530
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: December 20, 2011
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • Publication number: 20090252797
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: June 12, 2009
    Publication date: October 8, 2009
    Applicant: Galderma S.A.
    Inventors: Vincent MANETTA, Gary R. Watkins
  • Publication number: 20090227668
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: May 19, 2009
    Publication date: September 10, 2009
    Applicant: Galderma R&D
    Inventors: VINCENT MANETTA, GARY R. WATKINS
  • Patent number: 7550440
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: June 23, 2009
    Assignee: Galderma S.A.
    Inventors: Vincent Manetta, Gary R. Watkins
  • Publication number: 20060182688
    Abstract: Topically applicable pharmaceutical compositions suited for the treatment of dermatological complaints, conditions or afflictions, notably rosacea, contain a thus effective amount of metronidazole and at least one dye effective to impart a green color thereto, formulated into a topically applicable, pharmaceutically acceptable vehicle therefor.
    Type: Application
    Filed: December 19, 2005
    Publication date: August 17, 2006
    Applicant: GALDERMA S.A.
    Inventors: Nathalie Barthez, Sandrine Orsoni, Jessica Faust, Vincent Manetta, Laurent Fredon
  • Publication number: 20060100165
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: October 24, 2005
    Publication date: May 11, 2006
    Applicant: GALDERMA S.A.
    Inventors: Vincent Manetta, Gary Watkins